Ownership history in Nepsis Inc. Β· 19 quarters on record
This page tracks every 13F SEC filing in which Nepsis Inc. reported a position in MEDTRONIC INC (MDT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Nepsis Inc. underperformed the S&P 500 by β31.1% annually on this MDT position. Timing score: 50% (9/18 decisions correct). Average cost basis: $66.89. Maximum drawdown during holding period: β17.1%.
β Significantly underperformed the S&P 500 by 31.1% ann.
18 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
9 of 18 add/trim decisions correct
Best entry: $42.86 (2013 Q4) Β· Worst: $96.06 (2025 Q4)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
9 adds Β· 10 trims. Bought during 4 of 7 down-price quarters. π Predominantly trimming β distribution phase.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 2.63% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size